Several lines of evidence support an upward revision in pediatric hemodialy
sis dose guidelines: Although current recommendations are derived largely f
rom studies of dialysis mortality and morbidity in adults, recent reports o
f improved growth and pubertal development with more intensive dialysis hig
hlight the need for appropriate pediatric outcome measures in the assessmen
t of dialysis adequacy, particularly in prepubertal patients. Even if adult
studies can be extrapolated directly to younger patients, reappraisal of t
hese data would appear to justify an increase in recommended dialysis clear
ances, based on higher dietary protein intake and accumulating evidence tha
t adults, too, benefit from more intensive therapy. Suboptimal dialysis may
also occur when dialysis dose is overestimated by urea kinetic models that
fail to account for compartment effects and post-treatment urea rebound. S
tudies comparing the available models in pediatric patients have appeared r
ecently, and a few models have been developed specifically for pediatric ap
plications. These should permit more reliable estimates of solute clearance
for a much-needed multicenter trial to clarify optimal dialysis thera py f
or growing children.